期刊论文详细信息
GMS German Medical Science — an Interdisciplinary Journal
Parenteral nutrition in patients with renal failure – Guidelines on Parenteral Nutrition, Chapter 17Parenterale Ernährung bei Nierenversagen – Leitlinie Parenterale Ernährung, Kapitel 17
H. P. Kierdorf2  W. Druml1 
[1] Clinical Dept. of Nephrology and Dialysis, University of Vienna, Austria;Dept. Nephrology, Braunschweig, Germany
关键词: peritoneal dialysis;    haemodialysis;    chronic renal failure;    acute renal failure;   
Others  :  869128
实施日期:2009-01-14,发布日期:2009-11-18
PDF
【 摘 要 】

Partial EN (enteral nutrition) should always be aimed for in patients with renal failure that require nutritional support. Nevertheless PN (parenteral nutrition) may be necessary in renal failure in patient groups with acute or chronic renal failure (ARF or CRF) and additional acute diseases but without extracorporeal renal replacement therapy, or in patients with ARF or CRF with additional acute diseases on extracorporeal renal replacement therapy, haemodialysis therapy (HD), peritoneal dialysis (PD) or continuous renal replacement therapy (CRRT), or in patients on HD therapy with intradialytic PN. Patients with renal failure who show marked metabolic derangements and changes in nutritional requirements require the use of specifically adapted nutrient solutions. The substrate requirements of acutely ill, non-hypercatabolic patients with CRF correspond to those of patients with ARF who are not receiving any renal replacement patients therapy (utilisation of the administered nutrients has to be monitored carefully). In ARF patients and acutely ill CRF patients on renal replacement therapy, substrate requirements depend on disease severity, type and extent/frequency of extracorporeal renal replacement therapy, nutritional status, underlying disease and complications occurring during the course of the disease. Patients under HD have a higher risk of developing malnutrition. Intradialytic PN (IDPN) should be used if causes of malnutrition cannot be eliminated and other interventions fail. IDPN should only be carried out when modifiable causes of malnutrition are excluded and enhanced oral (like i.e. additional energy drinks) or enteral supply is unsuccessful or cannot be carried out.

【 授权许可】

   
© 2009 Druml et al.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.

【 预 览 】
附件列表
Files Size Format View
20140729193143399.pdf 1012KB PDF download
【 参考文献 】
  • [1]Lochs HL, Weimann A. DGEM-Leitlinie Enterale Ernährung [DGEM Guidelines Enteral Nutrition]. Akt Ernahrungsmed. 2003;28:S1-S120.
  • [2]Fiaccadori E, Lombardi M, Leonardi S, Rotelli CF, Tortorella G, Borghetti A. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol. 1999;10(3):581-93.
  • [3]Druml W. Nutritional management of acute renal failure. J Ren Nutr. 2005;15(1):63-70. DOI: 10.1053/j.jrn.2004.09.012 
  • [4]Clinical practice guidelines for nutrition in chronic renal failure; K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6 Suppl 2):S1-S140.
  • [5]Toigo G, Aparicio M, Attman PO, Cano N, Cianciaruso B, Engel B, Fouque D, Heidland A, Teplan V, Wanner C. Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2). Clin Nutr. 2000;19(4):281-91. DOI: 10.1054/clnu.2000.0129 
  • [6]Toigo G, Aparicio M, Attman PO, Cano N, Cianciaruso B, Engel B, Fouque D, Heidland A, Teplan V, Wanner C. Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clin Nutr. 2000;19(3):197-207. DOI: 10.1054/clnu.1999.0130 
  • [7]Druml W. Nutritional support in patients with acute renal failure. In: Molitoris BA, Finn WF, editors. Acute renal failure: A Companion to Brenner & Rector's "The Kidney". Philadelphia: WB Saunders, 2001. p. 465-89.
  • [8]Schneeweiss B, Graninger W, Stockenhuber F, Druml W, Ferenci P, Eichinger S, Grimm G, Laggner AN, Lenz K. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr. 1990;52(4):596-601.
  • [9]Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Picetti E, Parenti E, Meschi T, Borghi L, Tagliavini D, Cabassi A. Effects of different energy intakes on nitrogen balance in patients with acute renal failure: a pilot study. Nephrol Dial Transplant. 2005;20(9):1976-80. DOI: 10.1093/ndt/gfh956 
  • [10]Druml W, Fischer M, Sertl S, Schneeweiss B, Lenz K, Widhalm K. Fat elimination in acute renal failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr. 1992;55(2):468-72.
  • [11]Metnitz GH, Fischer M, Bartens C, Steltzer H, Lang T, Druml W. Impact of acute renal failure on antioxidant status in multiple organ failure. Acta Anaesthesiol Scand. 2000;44(3):236-40. DOI: 10.1034/j.1399-6576.2000.440304.x 
  • [12]Druml W, Schwarzenhofer M, Apsner R, Hörl WH. Fat-soluble vitamins in patients with acute renal failure. Miner Electrolyte Metab. 1998;24(4):220-26. DOI: 10.1159/000057374 
  • [13]Druml W. Metabolic aspects of continuous renal replacement therapies. Kidney Int Suppl. 1999;72:S56-S61. DOI: 10.1046/j.1523-1755.56.s72.1.x 
  • [14]Druml W, Fischer M, Liebisch B, Lenz K, Roth E. Elimination of amino acids in renal failure. Am J Clin Nutr. 1994;60(3):418-23.
  • [15]Druml W, Roth E, Lenz K, Lochs H, Kopsa H. Phenylalanine and tyrosine metabolism in renal failure: dipeptides as tyrosine source. Kidney Int Suppl. 1989;27:S282-6.
  • [16]Smolle KH, Kaufmann P, Fleck S, Lueger A, Mausser G, Pölz W, Kleinberger G, Krejs GJ. Influence of a novel amino acids solution (enriched with the dipeptide glycyl-tyrosine) on plasma amino acid concentration of patients with acute renal failure. Clin Nutr. 1997;16(5):239-46. DOI: 10.1016/S0261-5614(97)80035-0 
  • [17]Kierdorf HP. The nutritional management of acute renal failure in the intensive care unit. New Horiz. 1995;3(4):699-707.
  • [18]Mirtallo JM, Schneider PJ, Mavko K, Ruberg RL, Fabri PJ. A comparison of essential and general amino acid infusions in the nutritional support of patients with compromised renal function. JPEN J Parenter Enteral Nutr. 1982;6(2):109-13. DOI: 10.1177/0148607182006002109 
  • [19]Kehrer G, Blech M, Kallerhoff M, Kleinert H, Bretschneider HJ. Intraischemic metabolic effects of different disaccharides on protected canine kidneys. Urol Res. 1989;17(6):371-6. DOI: 10.1007/BF00510529 
  • [20]Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359-66. DOI: 10.1097/01.CCM.0000045568.12881.10 
  • [21]Berger MM, Shenkin A, Revelly JP, Roberts E, Cayeux MC, Baines M, Chioléro RL. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr. 2004;80(2):410-6.
  • [22]Story DA, Ronco C, Bellomo R. Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med. 1999;27(1):220-3. DOI: 10.1097/00003246-199901000-00057 
  • [23]Fortin MC, Amyot SL, Geadah D, Leblanc M. Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy. Intensive Care Med. 1999;25(6):594-8. DOI: 10.1007/s001340050908 
  • [24]Mashour S, Turner JF Jr, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest. 2000;118:561-3. DOI: 10.1378/chest.118.2.561 
  • [25]Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004;80(2):299-307.
  • [26]Druml W, Mitch WE. Enteral nutrition in renal disease. In: Rombeau JL, Rolandelli RH, editors. Clinical nutrition: Enteral and tube feeding. Philadelphia: WB Saunders; 1997. p. 439-61.
  • [27]Leblanc M, Garred LJ, Cardinal J, Pichette V, Nolin L, Ouimet D, Geadah D. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy. Am J Kidney Dis. 1998;32(3):444-53. DOI: 10.1053/ajkd.1998.v32.pm9740161 
  • [28]Chima CS, Meyer L, Hummell AC, Bosworth C, Heyka R, Paganini EP, Werynski A. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol. 1993;3(8):1516-21.
  • [29]Macias WL, Alaka KJ, Murphy MH, Miller ME, Clark WR, Mueller BA. Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure. JPEN J Parenter Enteral Nutr. 1996;20(1):56-62. DOI: 10.1177/014860719602000156 
  • [30]Bellomo R, Seacombe Bapplsci J, Daskalakis M, Farmer M, Wright C, Parkin G, Boyce N. A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure. Ren Fail. 1997;19(1):111-20. DOI: 10.3109/08860229709026265 
  • [31]Scheinkestel CD, Adams F, Mahony L, Bailey M, Davies AR, Nyulasi L, Tuxen DV. Impact of increasing parenteral protein loads on amino acid levels and balance in critically ill anuric patients on continuous renal replacement therapy. Nutrition. 2003;19(9):733-40. DOI: 10.1016/S0899-9007(03)00107-2 
  • [32]Scheinkestel CD, Kar L, Marshall K, Bailey M, Davies A, Nyulasi L, Tuxen DV. Prospective randomized trial to assess caloric and protein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition. 2003;19(11-12):909-16. DOI: 10.1016/S0899-9007(03)00175-8 
  • [33]Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. 1997;13(4):295-302.
  • [34]Zager RA. Amino acid hyperalimentation in acute renal failure: a potential therapeutic paradox. Kidney Int Suppl. 1987;22:S72-5.
  • [35]Abel RM, Beck CH Jr, Abbott WM, Ryan JA Jr, Barnett GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose: Results of a prospective, double-blind study. N Engl J Med. 1973;288(14):695-9.
  • [36]Pons M, Plante I, LeBrun M, Gourde P, Simard M, Grenier L, Thibault L, Labrecque G, Beauchamp D. Protein-rich diet attenuates cyclosporin A-induced renal tubular damage in rats. J Ren Nutr. 2003;13(2):84-92. DOI: 10.1053/jren.2003.50027 
  • [37]Kopple JD. Therapeutic approaches to malnutrition in chronic dialysis patients: the different modalities of nutritional support. Am J Kidney Dis. 1999;33(1):180-5. DOI: 10.1016/S0272-6386(99)70280-5 
  • [38]Aparicio M, Cano N, Chauveau P, Azar R, Flory A, Laville M, Leverve X. Nutritional status of haemodialysis patients: a French national cooperative study; French Study Group for Nutrition in Dialysis. Nephrol Dial Transplant. 1999;14(7):1679-86. DOI: 10.1093/ndt/14.7.1679 
  • [39]Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest. 2002;110(4):483-92.
  • [40]Veeneman JM, Kingma HA, Boer TS, Stellaard F, De Jong PE, Reijngoud DJ, Huisman RM. Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab. 2003;284(5):E954-65.
  • [41]Lazarus JM. Recommended criteria for initiating and discontinuing intradialytic parenteral nutrition therapy. Am J Kidney Dis. 1999;33(1):211-6. DOI: 10.1016/S0272-6386(99)70287-8 
  • [42]Czekalski S, Hozejowski R. Intradialytic amino acids supplementation in hemodialysis patients with malnutrition: results of a multicenter cohort study. J Ren Nutr. 2004;14(2):82-8. DOI: 10.1053/j.jrn.2004.01.007 
  • [43]Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int. 1982;21:500-6. DOI: 10.1038/ki.1982.52 
  • [44]Cano N, Labastie-Coeyrehourq J, Lacombe P, Stroumza P, di Costanzo-Dufetel J, Durbec JP, Coudray-Lucas C, Cynober L. Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr. 1990;52(4):726-30.
  • [45]Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG. The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis. 1994;24(6):912-20.
  • [46]Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA. Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis. 1994;23(6):808-16.
  • [47]Cano N. Intradialytic parenteral nutrition: where do we go from here? J Ren Nutr. 2004;14(1):3-5. DOI: 10.1053/j.jrn.2003.09.004 
  文献评价指标  
  下载次数:1次 浏览次数:13次